Cardiac Transplant - Missouri Perfusion...
Transcript of Cardiac Transplant - Missouri Perfusion...
![Page 1: Cardiac Transplant - Missouri Perfusion Societymissouriperfusion.com/wp-content/uploads/2019/05/6_Ricci-Wells_1345_Heart...Cancer Skin Cancer –most common 38% of all malignancies](https://reader034.fdocuments.in/reader034/viewer/2022050116/5f4d588215af474f7936077b/html5/thumbnails/1.jpg)
Cardiac Transplant Ricci Wells, RN, BSN
Nurse ManagerCardiac Transplant/VAD/Advanced Heart Failure
Mid America Heart InstituteSaint Luke’s Hospital of Kansas City
![Page 2: Cardiac Transplant - Missouri Perfusion Societymissouriperfusion.com/wp-content/uploads/2019/05/6_Ricci-Wells_1345_Heart...Cancer Skin Cancer –most common 38% of all malignancies](https://reader034.fdocuments.in/reader034/viewer/2022050116/5f4d588215af474f7936077b/html5/thumbnails/2.jpg)
Objectives:➢ History of Transplant
➢ Pre transplant Process
➢ Implantation
➢ Post transplant process
➢ Post transplant complications
![Page 3: Cardiac Transplant - Missouri Perfusion Societymissouriperfusion.com/wp-content/uploads/2019/05/6_Ricci-Wells_1345_Heart...Cancer Skin Cancer –most common 38% of all malignancies](https://reader034.fdocuments.in/reader034/viewer/2022050116/5f4d588215af474f7936077b/html5/thumbnails/3.jpg)
Heart TransplantHistory
First heart transplant was performed in
1967 in Cape Town, South Africa by
Dr. Christaan Barnard
![Page 4: Cardiac Transplant - Missouri Perfusion Societymissouriperfusion.com/wp-content/uploads/2019/05/6_Ricci-Wells_1345_Heart...Cancer Skin Cancer –most common 38% of all malignancies](https://reader034.fdocuments.in/reader034/viewer/2022050116/5f4d588215af474f7936077b/html5/thumbnails/4.jpg)
Heart Transplant“A new and disquieting look at transplants: The year they changed hearts”
“By 1971, 150 heart transplants world-wide with near 100% mortality from
rejection or infection.”
![Page 5: Cardiac Transplant - Missouri Perfusion Societymissouriperfusion.com/wp-content/uploads/2019/05/6_Ricci-Wells_1345_Heart...Cancer Skin Cancer –most common 38% of all malignancies](https://reader034.fdocuments.in/reader034/viewer/2022050116/5f4d588215af474f7936077b/html5/thumbnails/5.jpg)
Volume of Heart Transplants at SLH
0
5
10
15
20
25
30
35
40
45
50
![Page 6: Cardiac Transplant - Missouri Perfusion Societymissouriperfusion.com/wp-content/uploads/2019/05/6_Ricci-Wells_1345_Heart...Cancer Skin Cancer –most common 38% of all malignancies](https://reader034.fdocuments.in/reader034/viewer/2022050116/5f4d588215af474f7936077b/html5/thumbnails/6.jpg)
![Page 7: Cardiac Transplant - Missouri Perfusion Societymissouriperfusion.com/wp-content/uploads/2019/05/6_Ricci-Wells_1345_Heart...Cancer Skin Cancer –most common 38% of all malignancies](https://reader034.fdocuments.in/reader034/viewer/2022050116/5f4d588215af474f7936077b/html5/thumbnails/7.jpg)
Consultants:
Pulmonary, ID, GYN/Urology, GI, Psych, CTS,
Social Worker, Dietitian and Chaplain
If indicated: Endocrinology, Neurology
Labwork:
CBC, BMP, Coag, Lipids, CrCl, Serologies (HIV,
RPR, Hep B, Hep C), Toxicology, PSA (males),
Quant gold TB, Urine nicotine, ABO, CVM, VZ,
EBV
Testing/procedures:
Immunizations, CXR, PFT, MVO2, CT chest, Echo,
RHC, Carotid duplex, PV duplex, Panorex, Abd
sonogram, Pap smear/mammogram (females),
colonoscopy (pts over 50)
Evaluation Process
![Page 8: Cardiac Transplant - Missouri Perfusion Societymissouriperfusion.com/wp-content/uploads/2019/05/6_Ricci-Wells_1345_Heart...Cancer Skin Cancer –most common 38% of all malignancies](https://reader034.fdocuments.in/reader034/viewer/2022050116/5f4d588215af474f7936077b/html5/thumbnails/8.jpg)
Heart Transplant Candidate Selection
End stage cardiac disease with <50% 1 year
survival as defined by:• Stage D HF despite optimal medical and device therapy.Peak VO2 <12 or 50% predicted
>10% decrease on serial peak VO2
Selected unstable pts with higher VO2 may be considered.
• Intractable angina not amendable to percutaneous or surgical
therapy.
• Intractable ventricular dysrhythmias not amendable to
antiarrhythmic or percutaneous/surgical ablation.
• No expectation of improvement with alternative medical or
surgical treatment
![Page 9: Cardiac Transplant - Missouri Perfusion Societymissouriperfusion.com/wp-content/uploads/2019/05/6_Ricci-Wells_1345_Heart...Cancer Skin Cancer –most common 38% of all malignancies](https://reader034.fdocuments.in/reader034/viewer/2022050116/5f4d588215af474f7936077b/html5/thumbnails/9.jpg)
Heart Transplant Exclusion Criteria
• Age 66 years or greater. Selected patients greater than 65 years of
age may be considered on individual basis.
• Severe pulmonary HTN (PVR > 4)
• Irreversible renal or hepatic dysfunction – may consider dual organ
transplant for renal failure
• Systemic disease including but not limited to cirrhosis, severe
COPD, hx of cancer, symptomatic PAD/PVD, end organ diabetic
disease, poorly controlled diabetes and active hepatitis.
• Malignancy – varies by type and date of diagnosis
• Active infection
• Evidence of nicotine/alcohol/illegal substance use currently or
within the past 6 months.
• Morbid obesity with BMI > 35. Selected patients with BMI 36 – 40
may be considered on an individual basis.
• History of noncompliance
• Psychosocial or cognitive instability
• Lack of family/social support
• Lack of adequate financial coverage for ongoing transplant care.
![Page 10: Cardiac Transplant - Missouri Perfusion Societymissouriperfusion.com/wp-content/uploads/2019/05/6_Ricci-Wells_1345_Heart...Cancer Skin Cancer –most common 38% of all malignancies](https://reader034.fdocuments.in/reader034/viewer/2022050116/5f4d588215af474f7936077b/html5/thumbnails/10.jpg)
Coordination of Transplant
➢ Once donor/recipient are matched and heart is
accepted, surgeon and timing are coordinated
➢ Transplant Coordinator notifies CVOR team
(Recipient team and Donor team)
➢ Local donor vs. Non-local donor
![Page 11: Cardiac Transplant - Missouri Perfusion Societymissouriperfusion.com/wp-content/uploads/2019/05/6_Ricci-Wells_1345_Heart...Cancer Skin Cancer –most common 38% of all malignancies](https://reader034.fdocuments.in/reader034/viewer/2022050116/5f4d588215af474f7936077b/html5/thumbnails/11.jpg)
Removal of Donor Heart(Cardiectomy)
➢ Aorta and Pulmonary Artery
➢ Superior Vena Cava and Inferior Vena Cava
➢ Heparin IV given (300 units/kg)
➢ Cross clamp aorta
➢ Cardioplegia infused
![Page 12: Cardiac Transplant - Missouri Perfusion Societymissouriperfusion.com/wp-content/uploads/2019/05/6_Ricci-Wells_1345_Heart...Cancer Skin Cancer –most common 38% of all malignancies](https://reader034.fdocuments.in/reader034/viewer/2022050116/5f4d588215af474f7936077b/html5/thumbnails/12.jpg)
![Page 13: Cardiac Transplant - Missouri Perfusion Societymissouriperfusion.com/wp-content/uploads/2019/05/6_Ricci-Wells_1345_Heart...Cancer Skin Cancer –most common 38% of all malignancies](https://reader034.fdocuments.in/reader034/viewer/2022050116/5f4d588215af474f7936077b/html5/thumbnails/13.jpg)
![Page 14: Cardiac Transplant - Missouri Perfusion Societymissouriperfusion.com/wp-content/uploads/2019/05/6_Ricci-Wells_1345_Heart...Cancer Skin Cancer –most common 38% of all malignancies](https://reader034.fdocuments.in/reader034/viewer/2022050116/5f4d588215af474f7936077b/html5/thumbnails/14.jpg)
![Page 15: Cardiac Transplant - Missouri Perfusion Societymissouriperfusion.com/wp-content/uploads/2019/05/6_Ricci-Wells_1345_Heart...Cancer Skin Cancer –most common 38% of all malignancies](https://reader034.fdocuments.in/reader034/viewer/2022050116/5f4d588215af474f7936077b/html5/thumbnails/15.jpg)
![Page 16: Cardiac Transplant - Missouri Perfusion Societymissouriperfusion.com/wp-content/uploads/2019/05/6_Ricci-Wells_1345_Heart...Cancer Skin Cancer –most common 38% of all malignancies](https://reader034.fdocuments.in/reader034/viewer/2022050116/5f4d588215af474f7936077b/html5/thumbnails/16.jpg)
![Page 17: Cardiac Transplant - Missouri Perfusion Societymissouriperfusion.com/wp-content/uploads/2019/05/6_Ricci-Wells_1345_Heart...Cancer Skin Cancer –most common 38% of all malignancies](https://reader034.fdocuments.in/reader034/viewer/2022050116/5f4d588215af474f7936077b/html5/thumbnails/17.jpg)
![Page 18: Cardiac Transplant - Missouri Perfusion Societymissouriperfusion.com/wp-content/uploads/2019/05/6_Ricci-Wells_1345_Heart...Cancer Skin Cancer –most common 38% of all malignancies](https://reader034.fdocuments.in/reader034/viewer/2022050116/5f4d588215af474f7936077b/html5/thumbnails/18.jpg)
![Page 19: Cardiac Transplant - Missouri Perfusion Societymissouriperfusion.com/wp-content/uploads/2019/05/6_Ricci-Wells_1345_Heart...Cancer Skin Cancer –most common 38% of all malignancies](https://reader034.fdocuments.in/reader034/viewer/2022050116/5f4d588215af474f7936077b/html5/thumbnails/19.jpg)
De Vega Annuloplasty
![Page 20: Cardiac Transplant - Missouri Perfusion Societymissouriperfusion.com/wp-content/uploads/2019/05/6_Ricci-Wells_1345_Heart...Cancer Skin Cancer –most common 38% of all malignancies](https://reader034.fdocuments.in/reader034/viewer/2022050116/5f4d588215af474f7936077b/html5/thumbnails/20.jpg)
Post Transplant Recovery Process
CVICU – 24 to 48 hours
• Arrives sedated and intubated
• Maintain Hemodynamic stability
• Manage ventilation and oxygenation
• Recovery from anesthesia, pain management
• Wean from ventilator – goal is within 6 hours
• Monitor drainage output
Surgical Telemetry floor – 6 to 9 days (with no complications)
• Continue to monitor hemodynamic stability
• Patient increase ambulatory status
• Post transplant education (RN’s, Dietitian, Pharmacist, Physicians, Social
Workers, etc…)
![Page 21: Cardiac Transplant - Missouri Perfusion Societymissouriperfusion.com/wp-content/uploads/2019/05/6_Ricci-Wells_1345_Heart...Cancer Skin Cancer –most common 38% of all malignancies](https://reader034.fdocuments.in/reader034/viewer/2022050116/5f4d588215af474f7936077b/html5/thumbnails/21.jpg)
POST TRANSPLANT SCHEDULE
Clinic Visits – post transplant week 2, 3, 4, 6, 8, then monthly for 1st year,
every 3 months x 2 years and then every 6 months for life.
• Cardiac Biopsy at each visit up to 6 months and then as needed.
• AlloMap testing starting at 4 months through 3rd year.
• ECHO
• Stress Echo
• Chest x-ray
• ECG
• Lab – CSA/Tac levels, BMP, CBC, CMV, FLP
• Coronary angiogram at 6 weeks (baseline), 1, 3, 6, 10 years
Annual visits – additional Lab: TSH, Vitamin D level, HgbA1C, PSA,
testosterone
Bone density testing
Colonoscopy (> 50 yrs old every 5 years), Mammogram,
pap smear, prostate exam
![Page 22: Cardiac Transplant - Missouri Perfusion Societymissouriperfusion.com/wp-content/uploads/2019/05/6_Ricci-Wells_1345_Heart...Cancer Skin Cancer –most common 38% of all malignancies](https://reader034.fdocuments.in/reader034/viewer/2022050116/5f4d588215af474f7936077b/html5/thumbnails/22.jpg)
![Page 23: Cardiac Transplant - Missouri Perfusion Societymissouriperfusion.com/wp-content/uploads/2019/05/6_Ricci-Wells_1345_Heart...Cancer Skin Cancer –most common 38% of all malignancies](https://reader034.fdocuments.in/reader034/viewer/2022050116/5f4d588215af474f7936077b/html5/thumbnails/23.jpg)
Endomyocardial Biopsy
■ Standard for evaluating rejection
■ Done in the CV Cath Lab by the Transplant Cardiologist
■ No biopsies after 3 years unless symptomatic of rejection or have stopped
medications and may not need if Allomap scores are acceptable.
![Page 24: Cardiac Transplant - Missouri Perfusion Societymissouriperfusion.com/wp-content/uploads/2019/05/6_Ricci-Wells_1345_Heart...Cancer Skin Cancer –most common 38% of all malignancies](https://reader034.fdocuments.in/reader034/viewer/2022050116/5f4d588215af474f7936077b/html5/thumbnails/24.jpg)
Endomyocardial Biopsy
![Page 25: Cardiac Transplant - Missouri Perfusion Societymissouriperfusion.com/wp-content/uploads/2019/05/6_Ricci-Wells_1345_Heart...Cancer Skin Cancer –most common 38% of all malignancies](https://reader034.fdocuments.in/reader034/viewer/2022050116/5f4d588215af474f7936077b/html5/thumbnails/25.jpg)
AlloMap Test
■ Molecular gene expression testing – Blood sample to detect the absence of rejection.
■ Genes from WBC are analyzed
■ Results give an AlloMap score of 0 to 40
■ Draw at 4th and 5th month clinic visit with biopsy and compare the results of allomap with biopsy.
■ Our protocol is 4 – 6 months score < 30 and greater than 6 months score < 34.
■ At 6 month clinic visit, if allomap score is < 34 and biopsies have been negative, do not need further biopsies unless otherwise indicated.
![Page 26: Cardiac Transplant - Missouri Perfusion Societymissouriperfusion.com/wp-content/uploads/2019/05/6_Ricci-Wells_1345_Heart...Cancer Skin Cancer –most common 38% of all malignancies](https://reader034.fdocuments.in/reader034/viewer/2022050116/5f4d588215af474f7936077b/html5/thumbnails/26.jpg)
Triple drug therapy
Steroid
Prednisone*
Calcineurin Inhibitor
Cyclosporine
FK506
Tacrolimus*
Antimetabolite
Azothiaprin
Mycophenolate*
Immunosuppression
![Page 27: Cardiac Transplant - Missouri Perfusion Societymissouriperfusion.com/wp-content/uploads/2019/05/6_Ricci-Wells_1345_Heart...Cancer Skin Cancer –most common 38% of all malignancies](https://reader034.fdocuments.in/reader034/viewer/2022050116/5f4d588215af474f7936077b/html5/thumbnails/27.jpg)
Medication Side Effects
■ Tacrolimus – Headaches, tremors, tingling hands/feet, nausea/vomiting/diarrhea, HTN, decrease renal function, increase K+ and cholesterol, increase blood sugars
■ Cyclosporine – Tremors, hair growth, high blood pressure, increase K+ and cholesterol levels, muscle cramps, headaches
■ Mycophenalate – Nausea/vomiting/diarrhea, low WBC, anemia, increase risk of skin cancer
■ Steroids – Low WBC, HTN, osteoporosis, skin tears and bruising, increased appetite, sleeping difficulties, hair growth, mood swings, increase blood sugars, thrush
![Page 28: Cardiac Transplant - Missouri Perfusion Societymissouriperfusion.com/wp-content/uploads/2019/05/6_Ricci-Wells_1345_Heart...Cancer Skin Cancer –most common 38% of all malignancies](https://reader034.fdocuments.in/reader034/viewer/2022050116/5f4d588215af474f7936077b/html5/thumbnails/28.jpg)
How do we treat med side effects?
■ Check levels of meds and consider lower dose.
■ Other medications to treat side effects.
![Page 29: Cardiac Transplant - Missouri Perfusion Societymissouriperfusion.com/wp-content/uploads/2019/05/6_Ricci-Wells_1345_Heart...Cancer Skin Cancer –most common 38% of all malignancies](https://reader034.fdocuments.in/reader034/viewer/2022050116/5f4d588215af474f7936077b/html5/thumbnails/29.jpg)
Post transplant guidelines
■ Sternal precautions
■ Keep track of daily vital signs, weight, blood sugars
■ Visitors/family – masks, good hand washing
■ Pets
■ Travel
■ Tattoos/piercings/acrylic nails
■ Vaccinations
■ Dental care
![Page 30: Cardiac Transplant - Missouri Perfusion Societymissouriperfusion.com/wp-content/uploads/2019/05/6_Ricci-Wells_1345_Heart...Cancer Skin Cancer –most common 38% of all malignancies](https://reader034.fdocuments.in/reader034/viewer/2022050116/5f4d588215af474f7936077b/html5/thumbnails/30.jpg)
Complications
■ Rejection – Cellular and AMR
■ Coronary Disease/Graft Vasculopathy
■ Cancer
■ Infection
![Page 31: Cardiac Transplant - Missouri Perfusion Societymissouriperfusion.com/wp-content/uploads/2019/05/6_Ricci-Wells_1345_Heart...Cancer Skin Cancer –most common 38% of all malignancies](https://reader034.fdocuments.in/reader034/viewer/2022050116/5f4d588215af474f7936077b/html5/thumbnails/31.jpg)
Heart TransplantComplications
Infection
Drug side effects
Cancer
Coronary artery disease
Hypertension
Renal dysfunctionRejection
![Page 32: Cardiac Transplant - Missouri Perfusion Societymissouriperfusion.com/wp-content/uploads/2019/05/6_Ricci-Wells_1345_Heart...Cancer Skin Cancer –most common 38% of all malignancies](https://reader034.fdocuments.in/reader034/viewer/2022050116/5f4d588215af474f7936077b/html5/thumbnails/32.jpg)
Rejection
Acute Cellular Rejection – Surface cell antigens of donor heart
are recognized as foreign. Production of T cells.
■ Most common type of rejection
■ Signs and symptoms – “flu like” If severe, HF symptoms
and sometimes no symptoms at all.
Grading system – 0, 1R, 2R, 3R
■ 0 – No rejection - no treatment as long as therapeutic levels
■ 1R – Mild rejection – no treatment as long as therapeutic levels
■ 2R – Moderate rejection – protocol based with increase in oral
prednisone
■ 3R – Severe rejection – Admit, Solumedrol IV or Thymo protocol,
aggressive hemodynamic support (inotropes, IABP), activate for re-
transplant
![Page 33: Cardiac Transplant - Missouri Perfusion Societymissouriperfusion.com/wp-content/uploads/2019/05/6_Ricci-Wells_1345_Heart...Cancer Skin Cancer –most common 38% of all malignancies](https://reader034.fdocuments.in/reader034/viewer/2022050116/5f4d588215af474f7936077b/html5/thumbnails/33.jpg)
Heart TransplantCellular Rejection
![Page 34: Cardiac Transplant - Missouri Perfusion Societymissouriperfusion.com/wp-content/uploads/2019/05/6_Ricci-Wells_1345_Heart...Cancer Skin Cancer –most common 38% of all malignancies](https://reader034.fdocuments.in/reader034/viewer/2022050116/5f4d588215af474f7936077b/html5/thumbnails/34.jpg)
Rejection
Antibody Mediated Rejection (AMR) – Antibodies bind
to antigens on the endothelial surface
■ Not as common
Grading system
■ AMR 0 – both histological and immunopathological studies are negative
■ AMR 1 – Histopathological alone
■ AMR 2 - Both histological and immunopathological findings are positive
■ AMR 3 – Severe AMR
■ Diagnose and Treatment – Lab (PRA, DSA), Echo, Biopsy, maximize immunosuppression
![Page 35: Cardiac Transplant - Missouri Perfusion Societymissouriperfusion.com/wp-content/uploads/2019/05/6_Ricci-Wells_1345_Heart...Cancer Skin Cancer –most common 38% of all malignancies](https://reader034.fdocuments.in/reader034/viewer/2022050116/5f4d588215af474f7936077b/html5/thumbnails/35.jpg)
Rejection
■ Hyper-acute: Rare, happens in the OR or immediate post op. Rapid tissue necrosis.
Prognosis is poor. Fortunately incidence is < 1%. Risk factors – ABO mismatch
and antibodies to donor cells
■ Acute: First couple of months, incidence decreases with time. Occurs if
noncompliance with meds.
■ Chronic: > 6 months after transplant.
![Page 36: Cardiac Transplant - Missouri Perfusion Societymissouriperfusion.com/wp-content/uploads/2019/05/6_Ricci-Wells_1345_Heart...Cancer Skin Cancer –most common 38% of all malignancies](https://reader034.fdocuments.in/reader034/viewer/2022050116/5f4d588215af474f7936077b/html5/thumbnails/36.jpg)
Coronary Disease/Vasculopathy
■ A rapid and progressive form of CAD characterized by diffuse intimal stenosis that
effects entire length of vessel.
■ Intimal lesions can develop rapidly
■ Unlike CAD, calcification is rare in transplanted hearts
■ Clinical manifestations may include – increased fatigue, SOA, HF, dysrhythmias,
sudden death.
■ Diagnostic testing – Coronary angiogram with IVUS (intravascular ultrasound)
![Page 37: Cardiac Transplant - Missouri Perfusion Societymissouriperfusion.com/wp-content/uploads/2019/05/6_Ricci-Wells_1345_Heart...Cancer Skin Cancer –most common 38% of all malignancies](https://reader034.fdocuments.in/reader034/viewer/2022050116/5f4d588215af474f7936077b/html5/thumbnails/37.jpg)
Coronary Angiogram with IVUS
![Page 38: Cardiac Transplant - Missouri Perfusion Societymissouriperfusion.com/wp-content/uploads/2019/05/6_Ricci-Wells_1345_Heart...Cancer Skin Cancer –most common 38% of all malignancies](https://reader034.fdocuments.in/reader034/viewer/2022050116/5f4d588215af474f7936077b/html5/thumbnails/38.jpg)
Coronary Disease/Vasculopathy
Who is at risk?
■ Donor > 40 yrs old
■ Younger recipients
■ Older donor into young recipient
■ Continuation of smoking
■ Obesity
■ Ischemic time
■ Pre transplant diagnosis
■ Female diabetic donors
■ Intolerant to statin therapy
■ Diabetes
■ Chronic or multiple rejections
■ History of CMV infection
Constanzo MR et al, Are there specific risk factors for fatal allograft vasculopathy? An analysis of over 7,000 cardiac transplant patients. J Heart Lung Transplant 20:152,2001
![Page 39: Cardiac Transplant - Missouri Perfusion Societymissouriperfusion.com/wp-content/uploads/2019/05/6_Ricci-Wells_1345_Heart...Cancer Skin Cancer –most common 38% of all malignancies](https://reader034.fdocuments.in/reader034/viewer/2022050116/5f4d588215af474f7936077b/html5/thumbnails/39.jpg)
Coronary Disease/Vasculopathy
Preventative Treatment
■ Modification of risk factors – weight loss, lipid reduction, control of HTN, control of
DM, medical therapy (statins)
Treatment
■ Revascularization procedures – PTCA or CAB but are limited options because of
nature of diffuse disease.
■ Only definitive treatment is re-transplantation
![Page 40: Cardiac Transplant - Missouri Perfusion Societymissouriperfusion.com/wp-content/uploads/2019/05/6_Ricci-Wells_1345_Heart...Cancer Skin Cancer –most common 38% of all malignancies](https://reader034.fdocuments.in/reader034/viewer/2022050116/5f4d588215af474f7936077b/html5/thumbnails/40.jpg)
Cancer
Several factors have contributed to the increase in post transplant malignancies.
1. Improved graft survival and longer exposure to immunosuppression.
2. Use of more potent immunosuppression.
![Page 41: Cardiac Transplant - Missouri Perfusion Societymissouriperfusion.com/wp-content/uploads/2019/05/6_Ricci-Wells_1345_Heart...Cancer Skin Cancer –most common 38% of all malignancies](https://reader034.fdocuments.in/reader034/viewer/2022050116/5f4d588215af474f7936077b/html5/thumbnails/41.jpg)
CancerSkin Cancer – most common
■ 38% of all malignancies
■ SCC more frequently than BCC
■ Older recipients
■ Skin lesions are more aggressive
and incidence of multiple lesions
is higher
■ Relapses and metastasis are
more common
DeSalvo TG, The differing hazard of lymphoma vs. other malignancies in the current era.J Heart Lung Transplant 17:7,1998
![Page 42: Cardiac Transplant - Missouri Perfusion Societymissouriperfusion.com/wp-content/uploads/2019/05/6_Ricci-Wells_1345_Heart...Cancer Skin Cancer –most common 38% of all malignancies](https://reader034.fdocuments.in/reader034/viewer/2022050116/5f4d588215af474f7936077b/html5/thumbnails/42.jpg)
Cancer
Post Transplant Lymphoproliferative Disease (PTLD) – Involves wide spectrum of
disorders that range from benign hyperplasia to malignant lymphomas.
■ Incidence ranges from 2% in kidney recipients to 10% in heart/lung recipients.
■ Risk factors – intense immunosupression, EBV infection, CMV infection, type of
transplant
■ May or may not be symptomatic
![Page 43: Cardiac Transplant - Missouri Perfusion Societymissouriperfusion.com/wp-content/uploads/2019/05/6_Ricci-Wells_1345_Heart...Cancer Skin Cancer –most common 38% of all malignancies](https://reader034.fdocuments.in/reader034/viewer/2022050116/5f4d588215af474f7936077b/html5/thumbnails/43.jpg)
Cancer
Prevention of Cancer
■ Smoking cessation
■ Routine self exam of skin
■ Sun precautions – avoid sun exposure, wear protective clothing, sunscreen
■ Routine cancer screening – colonoscopy, prostate exam, mammogram, pap smear
![Page 44: Cardiac Transplant - Missouri Perfusion Societymissouriperfusion.com/wp-content/uploads/2019/05/6_Ricci-Wells_1345_Heart...Cancer Skin Cancer –most common 38% of all malignancies](https://reader034.fdocuments.in/reader034/viewer/2022050116/5f4d588215af474f7936077b/html5/thumbnails/44.jpg)
Heart TransplantInfection
Who is at risk ?
Older recipients
Debilitated recipient
Ventilator dependent
Previous sternotomy
Older donor into debilitated recipient
All of our patients
Young JB et al, Determinants of early graft failure following cardiac transplantation,A 10 year multi-institutional, multi-variable analysis J Heart Lung Transplant 20:212, 2001
Constanzo MR et al, Are there specific risk factors for fatal allograft vasculopathy? An analysis of over 7,000 cardiac transplant patients. J Heart Lung Transplant 20:152,2001
![Page 45: Cardiac Transplant - Missouri Perfusion Societymissouriperfusion.com/wp-content/uploads/2019/05/6_Ricci-Wells_1345_Heart...Cancer Skin Cancer –most common 38% of all malignancies](https://reader034.fdocuments.in/reader034/viewer/2022050116/5f4d588215af474f7936077b/html5/thumbnails/45.jpg)
Infection■ Respiratory Infection is most common (colds and
pneumonia)
Treatment - Antibiotic prophylaxis for 1 year after transplant
■ CMV (Cytomegalovirus) – GI tract is the most common site of CMV infection
Treatment – Antibiotic prophylaxis, depends on donor/recipient CMV + or –
■ Thrush – most common early due to high dose of steroids.
Treatment – Nystatin swish and swallow
![Page 46: Cardiac Transplant - Missouri Perfusion Societymissouriperfusion.com/wp-content/uploads/2019/05/6_Ricci-Wells_1345_Heart...Cancer Skin Cancer –most common 38% of all malignancies](https://reader034.fdocuments.in/reader034/viewer/2022050116/5f4d588215af474f7936077b/html5/thumbnails/46.jpg)
With all these potential complications, medication side effects, multiple
tests, procedures and clinic visits……
Why would anyone want a transplant?
![Page 47: Cardiac Transplant - Missouri Perfusion Societymissouriperfusion.com/wp-content/uploads/2019/05/6_Ricci-Wells_1345_Heart...Cancer Skin Cancer –most common 38% of all malignancies](https://reader034.fdocuments.in/reader034/viewer/2022050116/5f4d588215af474f7936077b/html5/thumbnails/47.jpg)
![Page 48: Cardiac Transplant - Missouri Perfusion Societymissouriperfusion.com/wp-content/uploads/2019/05/6_Ricci-Wells_1345_Heart...Cancer Skin Cancer –most common 38% of all malignancies](https://reader034.fdocuments.in/reader034/viewer/2022050116/5f4d588215af474f7936077b/html5/thumbnails/48.jpg)
![Page 49: Cardiac Transplant - Missouri Perfusion Societymissouriperfusion.com/wp-content/uploads/2019/05/6_Ricci-Wells_1345_Heart...Cancer Skin Cancer –most common 38% of all malignancies](https://reader034.fdocuments.in/reader034/viewer/2022050116/5f4d588215af474f7936077b/html5/thumbnails/49.jpg)
![Page 50: Cardiac Transplant - Missouri Perfusion Societymissouriperfusion.com/wp-content/uploads/2019/05/6_Ricci-Wells_1345_Heart...Cancer Skin Cancer –most common 38% of all malignancies](https://reader034.fdocuments.in/reader034/viewer/2022050116/5f4d588215af474f7936077b/html5/thumbnails/50.jpg)
![Page 51: Cardiac Transplant - Missouri Perfusion Societymissouriperfusion.com/wp-content/uploads/2019/05/6_Ricci-Wells_1345_Heart...Cancer Skin Cancer –most common 38% of all malignancies](https://reader034.fdocuments.in/reader034/viewer/2022050116/5f4d588215af474f7936077b/html5/thumbnails/51.jpg)
![Page 52: Cardiac Transplant - Missouri Perfusion Societymissouriperfusion.com/wp-content/uploads/2019/05/6_Ricci-Wells_1345_Heart...Cancer Skin Cancer –most common 38% of all malignancies](https://reader034.fdocuments.in/reader034/viewer/2022050116/5f4d588215af474f7936077b/html5/thumbnails/52.jpg)
Questions
![Page 53: Cardiac Transplant - Missouri Perfusion Societymissouriperfusion.com/wp-content/uploads/2019/05/6_Ricci-Wells_1345_Heart...Cancer Skin Cancer –most common 38% of all malignancies](https://reader034.fdocuments.in/reader034/viewer/2022050116/5f4d588215af474f7936077b/html5/thumbnails/53.jpg)
Bibliography
■ Transplantation Transplant Secrets, Linda Ohler and Sandra Cupples, 2003
■ Core Curriculum for Transplant Nurses, Linda Ohler and Sandra Cupples, 2008
■ Young JB et al, Determinants of early graft failure following cardiac transplantation,
A 10 year multi-institutional, multi-variable analysis J Heart Lung Transplant 20:212, 2001
■ Constanzo MR et al, Are there specific risk factors for fatal allograft vasculopathy?
An analysis of over 7,000 cardiac transplant patients. J Heart Lung Transplant 20:152,2001
■ DeSalvo TG, The differing hazard of lymphoma vs. other malignancies in the current era.
J Heart Lung Transplant 17:7,1998